Literature DB >> 20802169

An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease.

Mark D Eisner, Nicholas Anthonisen, David Coultas, Nino Kuenzli, Rogelio Perez-Padilla, Dirkje Postma, Isabelle Romieu, Edwin K Silverman, John R Balmes.   

Abstract

RATIONALE: Although cigarette smoking is the most important cause of chronic obstructive pulmonary disease (COPD), a substantial proportion of COPD cases cannot be explained by smoking alone.
OBJECTIVES: To evaluate the risk factors for COPD besides personal cigarette smoking.
METHODS: We constituted an ad hoc subcommittee of the American Thoracic Society Environmental and Occupational Health Assembly. An international group of members was invited, based on their scientific expertise in a specific risk factor for COPD. For each risk factor area, the committee reviewed the literature, summarized the evidence, and developed conclusions about the likelihood of it causing COPD. All conclusions were based on unanimous consensus.
MEASUREMENTS AND MAIN RESULTS: The population-attributable fraction for smoking as a cause of COPD ranged from 9.7 to 97.9%, but was less than 80% in most studies, indicating a substantial burden of disease attributable to nonsmoking risk factors. On the basis of our review, we concluded that specific genetic syndromes and occupational exposures were causally related to the development of COPD. Traffic and other outdoor pollution, secondhand smoke, biomass smoke, and dietary factors are associated with COPD, but sufficient criteria for causation were not met. Chronic asthma and tuberculosis are associated with irreversible loss of lung function, but there remains uncertainty about whether there are important phenotypic differences compared with COPD as it is typically encountered in clinical settings.
CONCLUSIONS: In public health terms, a substantive burden of COPD is attributable to risk factors other than smoking. To prevent COPD-related disability and mortality, efforts must focus on prevention and cessation of exposure to smoking and these other, less well-recognized risk factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802169     DOI: 10.1164/rccm.200811-1757ST

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  296 in total

1.  Basophils trigger emphysema development in a murine model of COPD through IL-4-mediated generation of MMP-12-producing macrophages.

Authors:  Sho Shibata; Kensuke Miyake; Tomoya Tateishi; Soichiro Yoshikawa; Yoshinori Yamanishi; Yasunari Miyazaki; Naohiko Inase; Hajime Karasuyama
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

Review 2.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

3.  The air we breathe and lung disease.

Authors:  Mary B Rice; Atul Malhotra
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

4.  Global and regional trends in COPD mortality, 1990-2010.

Authors:  Peter G J Burney; Jaymini Patel; Roger Newson; Cosetta Minelli; Mohsen Naghavi
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

5.  Inhibitors of ceramide de novo biosynthesis rescue damages induced by cigarette smoke in airways epithelia.

Authors:  Aida Zulueta; Anna Caretti; Giuseppe Matteo Campisi; Andrea Brizzolari; Jose Luis Abad; Rita Paroni; Paola Signorelli; Riccardo Ghidoni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-13       Impact factor: 3.000

6.  Association between chronic obstructive pulmonary disease and risk of erectile dysfunction: a systematic review and meta-analysis.

Authors:  Lianmin Luo; Shankun Zhao; Jiamin Wang; Yangzhou Liu; Zhiguo Zhu; Qian Xiang; ZhiGang Zhao
Journal:  Int J Impot Res       Date:  2019-07-01       Impact factor: 2.896

7.  Obstructive lung disease in Mexican Americans and non-Hispanic whites: an analysis of diagnosis and survival in the National Health and Nutritional Examination Survey III Follow-up Study.

Authors:  Alejandro A Diaz; Carolyn E Come; David M Mannino; Victor Pinto-Plata; Miguel J Divo; Carol Bigelow; Bartolome Celli; George R Washko
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

Review 8.  Exposure to nitrogen dioxide and chronic obstructive pulmonary disease (COPD) in adults: a systematic review and meta-analysis.

Authors:  Zili Zhang; Jian Wang; Wenju Lu
Journal:  Environ Sci Pollut Res Int       Date:  2018-03-20       Impact factor: 4.223

9.  The Association of Tobacco Use and Gender to Cardiac Rehabilitation Outcomes: A Preliminary Investigation.

Authors:  Andrea H Weinberger; Carolyn M Mazure; Sherry A McKee; Teresa Caulin-Glaser
Journal:  J Subst Use       Date:  2014-03-01

10.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.